Greenway Medical Technologies, Inc. Sustainability Profile
Greenway Medical Technologies, Inc., commonly referred to as Greenway, is a leading provider of healthcare technology solutions headquartered in the United States. Founded in 2000, the company has established a strong presence in the healthcare industry, focusing on electronic health records (EHR), practice management, and revenue cycle management. Greenway's innovative products, such as its integrated EHR platform, are designed to enhance clinical workflows and improve patient outcomes, setting them apart in a competitive market. With a commitment to empowering healthcare providers, Greenway has achieved significant milestones, including numerous industry awards for its technology and customer service excellence. As a trusted partner for healthcare organisations, Greenway continues to shape the future of healthcare delivery across the nation.
DitchCarbon Score
How does Greenway Medical Technologies, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Greenway Medical Technologies, Inc.'s score of 29 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Greenway Medical Technologies, Inc.'s reported carbon emissions
In 2024, Greenway Medical Technologies, Inc. reported total carbon emissions of approximately 104.7 million kg CO2e. This figure includes Scope 1 emissions of about 14.2 million kg CO2e and Scope 2 emissions of approximately 90.6 million kg CO2e. The previous year, 2023, the company recorded total emissions of about 110.8 million kg CO2e, with Scope 1 emissions at approximately 14.6 million kg CO2e and Scope 2 emissions at around 96.1 million kg CO2e. Greenway Medical Technologies is committed to achieving carbon neutrality for both the energy it purchases and its operational activities. This commitment is part of their near-term targets for Scope 1 and Scope 2 emissions, with a timeframe set from 2023 to 2025. The company has not disclosed any Scope 3 emissions data, indicating a potential area for future reporting and improvement. Overall, Greenway Medical Technologies is actively working towards reducing its carbon footprint and enhancing its environmental stewardship.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | |
|---|---|
| Scope 1 | 479,393,000 |
| Scope 2 | 12,072,000 |
| Scope 3 | - |
How Carbon Intensive is Greenway Medical Technologies, Inc.'s Industry?
How Carbon Intensive is Greenway Medical Technologies, Inc.'s Location?
Greenway Medical Technologies, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Greenway Medical Technologies, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
